Petlife Pharmaceuticals Inc. (PTLF)

[TradeForProfits]

$PTLF #venenotherapy very promising for #petcancer drug option: "As part of the pre-clinical study protocol, our Blue Scorpion venom formulation was evaluated in an Acute Toxicity study in mice (1). After administration for 14 days at 1X, 5X and 10X times dosing, the Blue Scorpion venom formulation was well tolerated and no adverse effects were observed at any of the dosing levels. All study animals gained weight as expected based on clinical observation and upon necropsy, there was no evidence to suggest any gross organ pathology."